210 related articles for article (PubMed ID: 2441268)
1. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
Kelly E; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
Kelly E; Nahorski SR
J Neurochem; 1986 Nov; 47(5):1512-6. PubMed ID: 2428936
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
4. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
Plantjé JF; Daus FJ; Hansen HA; Stoof JC
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):180-2. PubMed ID: 6208489
[TBL] [Abstract][Full Text] [Related]
5. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
6. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
J Neurosci; 1986 Aug; 6(8):2235-9. PubMed ID: 3018189
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
Stoof JC; Verheijden PF; Leysen JE
Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
[TBL] [Abstract][Full Text] [Related]
8. Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum.
Stoof JC; Kebabian JW
Brain Res; 1982 Nov; 250(2):263-70. PubMed ID: 6293642
[TBL] [Abstract][Full Text] [Related]
9. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
Zetterström T; Sharp T; Ungerstedt U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.
Wedzony K; Limberger N; Späth L; Wichmann T; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):250-5. PubMed ID: 3264055
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
Onali P; Olianas MC
Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical and behavioural evidence that dopamine D-2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation.
Kelly E; Willcocks AL; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):618-23. PubMed ID: 2819742
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.
Stoof JC; Kebabian JW
Nature; 1981 Nov; 294(5839):366-8. PubMed ID: 6273735
[No Abstract] [Full Text] [Related]
14. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens.
Merchant KM; Gibb JW; Hanson GR
Eur J Pharmacol; 1989 Feb; 160(3):409-12. PubMed ID: 2565819
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum.
Bidaut-Russell M; Howlett AC
J Neurochem; 1991 Nov; 57(5):1769-73. PubMed ID: 1681035
[TBL] [Abstract][Full Text] [Related]
16. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
17. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats.
Saigusa T; Koshikawa N; Kitamura M; Mizutani K; Kobayashi M; Cools AR
Eur J Pharmacol; 1995 Feb; 274(1-3):213-20. PubMed ID: 7539377
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
Drukarch B; Schepens E; Stoof JC
Neuroscience; 1990; 37(1):1-9. PubMed ID: 1978737
[TBL] [Abstract][Full Text] [Related]
19. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist.
White FJ
Eur J Pharmacol; 1987 Mar; 135(1):101-5. PubMed ID: 3494620
[TBL] [Abstract][Full Text] [Related]
20. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
